Physician profile
Sucharitha Vigneshwar
NPI 1427016526
$2,738.86
in general payments reported to CMS, 2019-2025
35 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $143 · 2021: $275 · 2022: $331 · 2023: $577 · 2024: $686 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.80 |
| Education | $105.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.94 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Organon LLC | $446.02 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $237.75 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $214.53 | 2019-2024 | |
| Lupin INC. | $155.35 | 2019-2021 | |
| Pfizer INC. | $132.98 | 2019-2024 | |
| Novo Nordisk INC | $114.73 | 2019-2025 | |
| Optumhealth Care Solutions, LLC | $79.80 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Mayne Pharma Commercial LLC | $72.79 | 2022-2025 | |
| Amgen INC. | $63.16 | 2023-2025 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $58.89 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $56.11 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $54.59 | 2024-2025 | |
| Myovant Sciences INC. | $46.30 | 2021-2022 | |
| Exeltis, USA INC. | $45.35 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $44.86 | 2024 | Zurzuvae |
| Covidien LP | $41.18 | 2019 | |
| Hologic Sales and Service, LLC | $33.01 | 2022-2024 | Aptima |
| Coopersurgical, INC. | $32.92 | 2019-2024 | Paragard T 380a |
| Agile Therapeutics, INC. | $31.92 | 2022 | |
| Minerva Surgical, INC | $31.39 | 2022-2024 | |
| Monaghan Medical Corporation | $28.04 | 2023 | Aerobika |
| Allergan, INC. | $26.77 | 2019 | |
| Mimedx Group, INC. | $26.39 | 2024 | |
| Vertical Pharmaceuticals, LLC | $23.14 | 2019 | |
| Aspira Women'S Health INC | $20.88 | 2023 | Ova1 |
| Medicem INC. | $20.64 | 2021 | |
| Mylan Pharmaceuticals INC. | $20.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.16 | 2019 | |
| Lilly USA, LLC | $18.75 | 2024 | Zepbound |
| Baxter Healthcare | $18.47 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $15.61 | 2019 | |
| Avion Pharmaceuticals | $13.56 | 2021 | |
| Renovia INC | $13.16 | 2021 | |
| Evofem Biosciences, INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sucharitha Vigneshwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.